Medpace Holdings Operating Income 2014-2024 | MEDP

Medpace Holdings annual/quarterly operating income history and growth rate from 2014 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Medpace Holdings operating income for the quarter ending September 30, 2024 was $0.112B, a 32.23% increase year-over-year.
  • Medpace Holdings operating income for the twelve months ending September 30, 2024 was $0.409B, a 25.43% increase year-over-year.
  • Medpace Holdings annual operating income for 2023 was $0.337B, a 20.86% increase from 2022.
  • Medpace Holdings annual operating income for 2022 was $0.279B, a 40.32% increase from 2021.
  • Medpace Holdings annual operating income for 2021 was $0.199B, a 18.9% increase from 2020.
Medpace Holdings Annual Operating Income
(Millions of US $)
2023 $337
2022 $279
2021 $199
2020 $167
2019 $127
2018 $101
2017 $65
2016 $52
2015 $21
2014 $4
2013 $59
Medpace Holdings Quarterly Operating Income
(Millions of US $)
2024-09-30 $112
2024-06-30 $105
2024-03-31 $104
2023-12-31 $87
2023-09-30 $85
2023-06-30 $78
2023-03-31 $86
2022-12-31 $76
2022-09-30 $78
2022-06-30 $60
2022-03-31 $64
2021-12-31 $55
2021-09-30 $54
2021-06-30 $42
2021-03-31 $48
2020-12-31 $55
2020-09-30 $46
2020-06-30 $30
2020-03-31 $36
2019-12-31 $36
2019-09-30 $30
2019-06-30 $35
2019-03-31 $26
2018-12-31 $31
2018-09-30 $27
2018-06-30 $23
2018-03-31 $20
2017-12-31 $15
2017-09-30 $17
2017-06-30 $16
2017-03-31 $16
2016-12-31 $13
2016-09-30 $13
2016-06-30 $14
2016-03-31 $13
2015-12-31
2015-09-30 $7
2014-12-31
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $10.498B $1.886B
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Viatris (VTRS) United States $15.958B 4.92
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00